249 related articles for article (PubMed ID: 35853858)
1. Alveolar macrophages: Achilles' heel of SARS-CoV-2 infection.
Wang Z; Li S; Huang B
Signal Transduct Target Ther; 2022 Jul; 7(1):242. PubMed ID: 35853858
[TBL] [Abstract][Full Text] [Related]
2. Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages.
Lv J; Wang Z; Qu Y; Zhu H; Zhu Q; Tong W; Bao L; Lv Q; Cong J; Li D; Deng W; Yu P; Song J; Tong WM; Liu J; Liu Y; Qin C; Huang B
Cell Discov; 2021 Apr; 7(1):24. PubMed ID: 33850112
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 evades immune detection in alveolar macrophages.
Dalskov L; Møhlenberg M; Thyrsted J; Blay-Cadanet J; Poulsen ET; Folkersen BH; Skaarup SH; Olagnier D; Reinert L; Enghild JJ; Hoffmann HJ; Holm CK; Hartmann R
EMBO Rep; 2020 Dec; 21(12):e51252. PubMed ID: 33112036
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages.
Wang Z; Lv J; Yu P; Qu Y; Zhou Y; Zhou L; Zhu Q; Li S; Song J; Deng W; Gao R; Liu Y; Liu J; Tong WM; Qin C; Huang B
Cell Mol Immunol; 2022 Feb; 19(2):210-221. PubMed ID: 34983944
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 Coronavirus spike protein analysis for synthetic vaccines, a peptidomimetic antagonist, and therapeutic drugs, and analysis of a proposed achilles' heel conserved region to minimize probability of escape mutations and drug resistance.
Robson B
Comput Biol Med; 2020 Jun; 121():103749. PubMed ID: 32568687
[TBL] [Abstract][Full Text] [Related]
6. Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets.
Park SJ; Yu KM; Kim YI; Kim SM; Kim EH; Kim SG; Kim EJ; Casel MAB; Rollon R; Jang SG; Lee MH; Chang JH; Song MS; Jeong HW; Choi Y; Chen W; Shin WJ; Jung JU; Choi YK
mBio; 2020 May; 11(3):. PubMed ID: 32444382
[TBL] [Abstract][Full Text] [Related]
7. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
8. The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines.
Murano K; Guo Y; Siomi H
Biochem Soc Trans; 2021 Dec; 49(6):2879-2890. PubMed ID: 34854887
[TBL] [Abstract][Full Text] [Related]
9. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
10. The Chronicle of COVID-19 and Possible Strategies to Curb the Pandemic.
Kumar R; Harilal S; Al-Sehemi AG; Mathew GE; Carradori S; Mathew B
Curr Med Chem; 2021; 28(15):2852-2886. PubMed ID: 32614740
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based systematic review on emerging therapeutic and preventive strategies to treat novel coronavirus (SARS-CoV-2) during an outbreak scenario.
Gudadappanavar AM; Benni J
J Basic Clin Physiol Pharmacol; 2020 Sep; 31(6):. PubMed ID: 32924964
[TBL] [Abstract][Full Text] [Related]
13. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
Frederiksen LSF; Zhang Y; Foged C; Thakur A
Front Immunol; 2020; 11():1817. PubMed ID: 32793245
[TBL] [Abstract][Full Text] [Related]
14. Drug Discovery Strategies for SARS-CoV-2.
Shyr ZA; Gorshkov K; Chen CZ; Zheng W
J Pharmacol Exp Ther; 2020 Oct; 375(1):127-138. PubMed ID: 32723801
[TBL] [Abstract][Full Text] [Related]
15. A Review of Potential Therapeutic Strategies for COVID-19.
Meng J; Li R; Zhang Z; Wang J; Huang Q; Nie D; Fan K; Guo W; Zhao Z; Han Z
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366444
[TBL] [Abstract][Full Text] [Related]
16. Metal-based strategies for the fight against COVID-19.
Li H; Yuan S; Wei X; Sun H
Chem Commun (Camb); 2022 Jul; 58(54):7466-7482. PubMed ID: 35730442
[TBL] [Abstract][Full Text] [Related]
17. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Pandemic-Therapeutics in Warp Speed.
Sen S; Kumar N
Recent Adv Antiinfect Drug Discov; 2023; 18(2):110-119. PubMed ID: 36655526
[TBL] [Abstract][Full Text] [Related]
19. Rapid in vitro assays for screening neutralizing antibodies and antivirals against SARS-CoV-2.
Park JG; Oladunni FS; Chiem K; Ye C; Pipenbrink M; Moran T; Walter MR; Kobie J; Martinez-Sobrido L
J Virol Methods; 2021 Jan; 287():113995. PubMed ID: 33068703
[TBL] [Abstract][Full Text] [Related]
20. COVID-19/SARS-CoV-2 Infection: Lysosomes and Lysosomotropism Implicate New Treatment Strategies and Personal Risks.
Blaess M; Kaiser L; Sauer M; Csuk R; Deigner HP
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32668803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
